Citations (165)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (23)
Vibeke Strand, Lixia Zhang, Alix Arnaud, Erin Connolly-Strong, Sam Asgarian & Johanna B Withers. (2022) Improvement in clinical disease activity index when treatment selection is informed by the tumor necrosis factor-ɑ inhibitor molecular signature response classifier: analysis from the study to accelerate information of molecular signatures in rheumatoid arthritis. Expert Opinion on Biological Therapy 22:6, pages 801-807.
Read now
Read now
Muhammad Safwan Akram, Neelam Pery, Lucy Butler, Muhammad Imtiaz Shafiq, Nayab Batool, Muhammad Fayyaz ur Rehman, Luke G. Grahame-Dunn & Ali K. Yetisen. (2021) Challenges for biosimilars: focus on rheumatoid arthritis. Critical Reviews in Biotechnology 41:1, pages 121-153.
Read now
Read now
Vardhaman Patel, Zulkarnain Pulungan, Anne Shah, Mahesh Kambhampati, Francis Lobo & Allison Petrilla. (2021) Risk and cost of infection-related hospitalizations in medicare beneficiaries with comorbid rheumatoid arthritis treated with abatacept versus other targeted disease-modifying anti-rheumatic drugs. Journal of Medical Economics 24:1, pages 299-307.
Read now
Read now
Damemarie Paul, Dhaval Patil, Laura McDonald, Vardhaman Patel & Francis Lobo. (2020) Comparison of infection-related hospitalization risk and costs in tumor necrosis factor inhibitor-experienced patients with rheumatoid arthritis (RA) treated with abatacept or other targeted disease-modifying anti-rheumatic drugs (tDMARDs). Journal of Medical Economics 23:9, pages 1025-1031.
Read now
Read now
Miao-Chiu Lin, Hanoch Livneh, Wei-Jen Chen, Ning-Sheng Lai, Ming-Chi Lu & Tzung-Yi Tsai. (2020) Association of Chinese Herbal Medicines Use with Development of Chronic Obstructive Pulmonary Disease Among Patients with Rheumatoid Arthritis: A Population-Based Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 691-700.
Read now
Read now
Lorie A Ellis, Elisabetta Malangone-Monaco, Helen Varker, Diana Stetsovsky, Maureen Kubacki, Raphael J DeHoratius & Shelly Kafka. (2019) Comparative analysis of US real-world dosing patterns and direct infusion-related costs for matched cohorts of rheumatoid arthritis patients treated with infliximab or intravenous golimumab. ClinicoEconomics and Outcomes Research 11, pages 99-110.
Read now
Read now
Nan Li, Edmond Chan & Steve Peterson. (2019) The economic burden of depression among adults with rheumatoid arthritis in the United States. Journal of Medical Economics 22:4, pages 372-378.
Read now
Read now
Ahva Shahabi, Jason Shafrin, Lauren Zhao, Sarah Green, Tammy Curtice, Alexander Marshall & Damemarie Paul. (2019) The economic burden of switching targeted disease-modifying anti-rheumatic drugs among rheumatoid arthritis patients. Journal of Medical Economics 22:4, pages 350-358.
Read now
Read now
Peter A Fischer & Ronald J Rapoport. (2018) Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies. Open Access Rheumatology: Research and Reviews 10, pages 13-19.
Read now
Read now
Cheryl P Ferrufino, Julie Munakata, Wenhui Wei, Clare Proudfoot, Andreas Kuznik, Susan H Boklage & Chieh-I Chen. (2018) Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies. ClinicoEconomics and Outcomes Research 10, pages 805-819.
Read now
Read now
Marita Zimmermann, Elisabeth Vodicka, Andrew J. Holman & Louis P. Garrison$suffix/text()$suffix/text(). (2018) Heart rate variability testing: could it change spending for rheumatoid arthritis patients in the United States? An exploratory economic analysis. Journal of Medical Economics 21:7, pages 712-720.
Read now
Read now
Edel Shannon, Joanne Daffy, Heather Jones, Andrea Paulson & Steven M Vicik. (2017) Etanercept (Enbrel®) alternative storage at ambient temperature. Clinical Pharmacology: Advances and Applications 9, pages 87-99.
Read now
Read now
Jeroen P. Jansen, Devin Incerti, Alex Mutebi, Desi Peneva, Joanna P. MacEwan, Bradley Stolshek, Primal Kaur, Mahdi Gharaibeh & Vibeke Strand. (2017) Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators. Journal of Medical Economics 20:7, pages 703-714.
Read now
Read now
Angel M. Dzhambov & Donka D. Dimitrova. (2017) Lifetime exposure to self-reported occupational noise and prevalent rheumatoid arthritis in the National Health and Nutrition Examination Survey (2011–2012). International Journal of Occupational and Environmental Health 23:3, pages 215-221.
Read now
Read now
Marco Krasselt & Christoph Baerwald. (2016) Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis. Drug Design, Development and Therapy 10, pages 1047-1058.
Read now
Read now
Namita Tundia, Paulo Gustavo Kotze, Jorge Rojas Serrano, Mirhelen Mendes de Abreu, Martha Skup, Dendy Macaulay, James Signorovitch, Leonardo Chaves, Jingdong Chao & Yanjun Bao. (2016) Economic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn’s disease in Argentina, Brazil, Colombia, and Mexico. Journal of Medical Economics 19:12, pages 1187-1199.
Read now
Read now
László Gulácsi, Valentin Brodszky, Petra Baji, HoUng Kim, Su Yeon Kim, Yu Young Cho & Márta Péntek. (2015) Biosimilars for the management of rheumatoid arthritis: economic considerations. Expert Review of Clinical Immunology 11:sup1, pages 43-52.
Read now
Read now
Machaon Bonafede, Barbara H. Johnson, Nicole Princic, Neel Shah & David J. Harrison. (2015) Cost per patient-year in response using a claims-based algorithm for the 2 years following biologic initiation in patients with rheumatoid arthritis. Journal of Medical Economics 18:5, pages 376-389.
Read now
Read now
Martin Bergman, Gourab De, Arijit Ganguli, James Signorovitch & Yanjun Bao. (2015) Assessment of income growth in patients with rheumatoid arthritis treated with anti-tumor necrosis factor therapy. Journal of Medical Economics 18:1, pages 37-44.
Read now
Read now
Nicole W Tsao, Kam Shojania & Carlo A Marra. (2014) Cost–effectiveness of abatacept for moderate-to-severe rheumatoid arthritis. Expert Review of Pharmacoeconomics & Outcomes Research 14:1, pages 9-18.
Read now
Read now
Amie T. Joyce, Shravanthi R. Gandra, Kathleen M. Fox, Timothy W. Smith & Michael W. Pill. (2014) National and regional dose escalation and cost of tumor necrosis factor blocker therapy in biologic-naïve rheumatoid arthritis patients in US health plans. Journal of Medical Economics 17:1, pages 1-10.
Read now
Read now
Matthew Metzgar. (2012) Externalities from grain consumption: a survey. International Journal of Food Sciences and Nutrition 63:4, pages 453-460.
Read now
Read now
V.F. Schabert, B. Bruce, C.F. Ferrufino, D.R. Globe, D.J. Harrison, B. Lingala & J.F. Fries. (2012) Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study. Current Medical Research and Opinion 28:4, pages 569-580.
Read now
Read now
Articles from other publishers (142)
Dominik Grega & Jozef Kolář. (2024) The Economic Burden of Biological Drugs in Rheumatoid Arthritis Treatment. Value in Health Regional Issues 40, pages 13-18.
Crossref
Crossref
Deborah A. Marshall, Brittany Gerber, Diane L. Lorenzetti, Karen V. MacDonald, Riley Jewel Bohach & Gillian R. Currie. (2023) Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies. PharmacoEconomics 41:12, pages 1563-1588.
Crossref
Crossref
Jie Xu, Meng Chen, Yingli YuLiugang TangXiaobing Luo & Yuandong Cheng. (2023) Global research hotspots and trends in exercise interventions for rheumatoid arthritis over the past two decades: A bibliometric and visualization study. Medicine 102:46, pages e36030.
Crossref
Crossref
Fangyuan Yu, Hongwei Chen, Qi Li, Mengjun Tao, Ziyi Jin, Linyu Geng & Lingyun Sun. (2023) Secular trend of mortality and incidence of rheumatoid arthritis in global ,1990–2019: an age period cohort analysis and joinpoint analysis. BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Marialaura Madrigal, Patricia L. Fernández, Ricardo Lleonart, Lizmar Carreño, Kaiser Alejandro Villalobos Gorday, Ellís Rodríguez, Kathya de Cupeiro, Carlos M. Restrepo, K. S. Jagannatha Rao & Neil H. Riordan. (2023) Comparison of Cost and Potency of Human Mesenchymal Stromal Cell Conditioned Medium Derived from 2- and 3-Dimensional Cultures. Bioengineering 10:8, pages 930.
Crossref
Crossref
Yuntong Ma, Ian Pan, Stanley Y. Kim, Ged G. Wieschhoff, Katherine P. Andriole & Jacob C. Mandell. (2023) Deep learning discrimination of rheumatoid arthritis from osteoarthritis on hand radiography. Skeletal Radiology.
Crossref
Crossref
Robert Freeze, Kelly W. Yang, Timothy Haystead, Philip Hughes & Scott Scarneo. (2023)
Delineation of the distinct inflammatory signaling roles of
TAK1
and
JAK1
/3 in the
CIA
model of rheumatoid arthritis
. Pharmacology Research & Perspectives 11:4.
Crossref
Crossref
Leticia Massimo Pereira, Natalia Cristina Gomes-da-Silva, Martha Sahylí Ortega Pijeira, Filipe Leal Portilho, Andrezza Santos Cordeiro, Luciana Magalhães Rebelo Alencar, Luana Barbosa Corrêa, Maria das Graças Henriques, Ralph Santos-Oliveira & Elaine Cruz Rosas. (2023) Methyl gallate nanomicelles impairs neutrophil accumulated in zymosan-induced arthritis. Colloids and Surfaces B: Biointerfaces 227, pages 113351.
Crossref
Crossref
Saad Saleem, Zahid Ijaz Tarar, Waseem Amjad, Adnan Malik, Rizwan Ishtiaq & Thomas L. Abell. (2023) Association between Gastroparesis and Rheumatoid Arthritis: A US Population–Based Study. Southern Medical Journal 116:6, pages 443-447.
Crossref
Crossref
Paul Walter, Chien‐Kai Kau & Chih‐Wei Chen. (2023) A platform‐based approach to assisting rheumatoid arthritis management. International Journal of Rheumatic Diseases 26:6, pages 1019-1021.
Crossref
Crossref
Ryan C. Williams, Maame Yaa O. Brako, William Guo, Hunya Usmani, Sean Na & Richard A. F. Clark. (2023) The uni-directional association of atopic dermatitis and rheumatoid arthritis: a systematic review and meta-analysis. Archives of Dermatological Research 315:8, pages 2261-2269.
Crossref
Crossref
Annette de Thurah, Henry Jensen, Thomas Maribo, Martin B Jensen, Annelli Sandbæk, Ellen-Margrethe Hauge & Linda Aa Rasmussen. (2023) Use of primary health care and radiological imaging preceding a diagnosis of rheumatoid arthritis: a nationwide cohort study in Denmark. Rheumatology 62:2, pages 555-564.
Crossref
Crossref
Nadia G Obaed, Mohamed Elsheshtawi, Can Jones, Vivek Kothari, Tabitha Estica, Kristina Menchaca & Shaun Isaac. (2023) Functional Quadriplegia as an Initial Presentation of Severe Rheumatoid Arthritis. Cureus.
Crossref
Crossref
Jon Arnason, MD, Ann Chodara, MD, Shivani Garg, MD, MS, Karen Hansen, MD, MS, Julie Hildebrand, MD, Tiffany Lin, MD & Christie M. Bartels, MD, MS. 2023. Chronic Disease Epidemiology, Prevention, and Control, 5th edition. Chronic Disease Epidemiology, Prevention, and Control, 5th edition.
Joshua J Solomon, Sonye K Danoff, Felix A Woodhead, Shelley Hurwitz, Rie Maurer, Ian Glaspole, Paul F Dellaripa, Bibek Gooptu, Robert Vassallo, P Gerard Cox, Kevin R Flaherty, Huzaifa I Adamali, Michael A Gibbons, Lauren Troy, Ian A Forrest, Joseph A Lasky, Lisa G Spencer, Jeffrey Golden, Mary Beth Scholand, Nazia Chaudhuri, Mark A Perrella, David A Lynch, Daniel C Chambers, Martin Kolb, Cathie Spino, Ganesh Raghu, Hilary J Goldberg, Ivan O Rosas, Shana Haynes-Harp, Fernando Poli, Coimbatore Sree Vidya, Rebecca R. Baron, Timothy Clouser, Tracy Doyle, Anthony Maeda, Kristin B. Highland, Jemima F. Albayda, Sarah E. Collins, Karthik S. Suresh, John M. Davis, Andrew H. Limper, Isabel Amigues, Kristina Eliopoulos, Jeffery J. Swigris, Stephen Humphries, John C. Huntwork, Chris Glynn, Steve R. Duncan, Maria I. Danila, Marilyn K. Glassberg, Elana M. Oberstein, Elizabeth A. Belloli, Linda Briggs, Vivek Nagaraja, Linda Cholewa, Donna DiFranco, Edward Green, Christie Liffick, Tanvi Naik, Genevieve Montas, Dorota Lebiedz-Odrobina, Reba Bissell, Mark Wener, Lisa H. Lancaster, Leslie J. Crawford, Karmela Chan, Robert J. Kaner, Alicia Morris, Xiaoping Wu, Nader A. Khalidi, Christopher J. Ryerson, Alyson W. Wong, Charlene D. Fell, Sharon A. LeClercq, Mark Hyman, Shane Shapera, Shikha Mittoo, Shireen Shaffu, Karl Gaffney, Andrew M. Wilson, Shaney Barratt, Harsha Gunawardena, Rachel K. Hoyles, Joel David, Namrata Kewalramani, Toby M. Maher, Philip L. Molyneaux, Maria A. Kokosi, Matthew J. Cates, Mandizha Mandizha, Abdul Ashish, Gladstone Chelliah, Helen Parfrey, Muhunthan Thillai, Josephine Vila, Sophie V. Fletcher, Paul Beirne, Clair Favager, Jo Brown, Julie K. Dawson, Pilar Rivera Ortega, Sahena Haque, Pippa Watson, Jun K. Khoo, Karen Symons, Peter Youssef & John A. Mackintosh. (2023) Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. The Lancet Respiratory Medicine 11:1, pages 87-96.
Crossref
Crossref
George A. Kelley & Kristi S. Kelley. (2022) Representation of adults with rheumatoid arthritis in US-based randomized controlled exercise trials: a systematic review with meta-analysis. Clinical Rheumatology 42:1, pages 29-38.
Crossref
Crossref
Joshua J. Solomon, Kevin Brown & Mary Kristen Demoruelle. 2023. Orphan Lung Diseases. Orphan Lung Diseases
207
221
.
Alix Bird, Lauren Oakden-Rayner, Christopher McMaster, Luke A. Smith, Minyan Zeng, Mihir D. Wechalekar, Shonket Ray, Susanna Proudman & Lyle J. Palmer. (2022) Artificial intelligence and the future of radiographic scoring in rheumatoid arthritis: a viewpoint. Arthritis Research & Therapy 24:1.
Crossref
Crossref
Anne V. Seyferth, Meghan N. Cichocki, Chien-Wei Wang, Yun-Ju Huang, Yi-Wei Huang, Jung-Sheng Chen, Chang-Fu Kuo & Kevin C. Chung. (2022) Factors Associated With Quality Care Among Adults With Rheumatoid Arthritis. JAMA Network Open 5:12, pages e2246299.
Crossref
Crossref
Jeffrey R. Curtis, Kathleen M. Fox, Fenglong Xie, Yujie Su, David Collier, Cassie Clinton & Hafiz Oko-osi. (2022) The Economic Benefit of Remission for Patients with Rheumatoid Arthritis. Rheumatology and Therapy 9:5, pages 1329-1345.
Crossref
Crossref
Axel Finckh, Benoît Gilbert, Bridget Hodkinson, Sang-Cheol Bae, Ranjeny Thomas, Kevin D. Deane, Deshiré Alpizar-Rodriguez & Kim Lauper. (2022) Global epidemiology of rheumatoid arthritis. Nature Reviews Rheumatology.
Crossref
Crossref
Dimitrios A. Pappas, Christine Brittle, Andrew Concoff, Andrew J. Holman, Dennis Takasugi & Joel M. Kremer. (2022) Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey. Rheumatology International 42:9, pages 1555-1564.
Crossref
Crossref
Stuart Silverman, Sheena Thakkar, Heather Sell, Alan G. White, Nathaniel Downes, William Pajerowski, Rebecca L. Robinson, Craig G. Beck, Birol Emir & Patricia Schepman. (2022) All-Cause Health Care and Work Loss Burden Associated With Nonsteroidal Anti-Inflammatory Drug and Opioid Treatment in Employed Patients With Osteoarthritis. Journal of Occupational & Environmental Medicine 64:8, pages 699-706.
Crossref
Crossref
Vardhaman Patel, Zulkarnain Pulungan, Anne Shah, Barton Jones, Allison Petrilla, Leticia Ferri, Xue Han & Kaleb Michaud. (2022) Diabetes-Related Complications and Costs in Medicare Beneficiaries with Comorbid Rheumatoid Arthritis and Diabetes Treated with Abatacept Versus Other Targeted DMARDs. Rheumatology and Therapy 9:4, pages 1091-1107.
Crossref
Crossref
Elahe Hatami, Mobina Aghajani, Makan Pourmasoumi, Farahnaz Haeri, Behnoosh Boozari, Saeed Nezamoleslami, Cain C. T. Clark, Shokufeh Nezamoleslami & Reza Ghiasvand. (2022) The relationship between animal flesh foods consumption and rheumatoid arthritis: a case-control study. Nutrition Journal 21:1.
Crossref
Crossref
Sung Soo Ahn, Hyunsun Lim, Chan Hee Lee, Yong-Beom Park, Jin-Su Park & Sang-Won Lee. (2022) Secular Trends of Incidence, Prevalence, and Healthcare Economic Burden in ANCA-Associated Vasculitis: An Analysis of the 2002–2018 South Korea National Health Insurance Database. Frontiers in Medicine 9.
Crossref
Crossref
Elizabeth Salt, Amanda T. Wiggins, Nancy Grant Harrington, Mary Kay Rayens & Kristine Lohr. (2021) Evaluation of a medication optimization intervention and predictors of medication adherence, patient satisfaction and medication adverse events in patients with rheumatoid arthritis. Musculoskeletal Care 20:2, pages 321-329.
Crossref
Crossref
Joshua J Solomon, Jeffrey J Swigris, Michael Kreuter, Markus Polke, Kerri Aronson, Anna-Maria Hoffmann-Vold & Paul F Dellaripa. (2022) The attitudes and practices of physicians caring for patients with rheumatoid arthritis-associated interstitial lung disease: an international survey. Rheumatology 61:4, pages 1459-1467.
Crossref
Crossref
Eory Madera Miranda, Xue Han, Sang Hee Park, Sonick Suri & Manasi Suryavanshi. (2022) Treatment Patterns Among Patients with Rheumatoid Arthritis in Puerto Rico. Rheumatology and Therapy 9:2, pages 609-619.
Crossref
Crossref
Phillip D. Rumrill, Lynn C. Koch, Mirang Park, Deborah Lee & Malachy L. Bishop. (2022) Rheumatoid Arthritis as an Emerging Disability: Vocational Rehabilitation Strategies in the Wake of the Coronavirus Pandemic. Rehabilitation Research, Policy, and Education 36:1, pages 60-70.
Crossref
Crossref
Yanying Liu, Shengyun Liu, Lin Liu, Xiaowei Gong, Ju Liu, Lingyun Sun, Xiumei Liu, Lijun Wu, Linjie Chen, Ling Wang, Li Luo, Jinying Lin, Ning Tie, Zhenyu Jiang, Jian Wu, Fuai Lu, Hongsheng Sun, Xiaomei Li, Niansheng Yang, Kexia Chai, Hua Wei, Zhanyun Da, Cheng Zhao, Lie Dai, Youlian Wang, Guixiu Shi, Zhenchun Zhang, Hui Song, Qian Guo, Yingxue Cathy Liu & Zhanguo Li. (2021) Fine Comparison of the Efficacy and Safety Between GB242 and Infliximab in Patients with Rheumatoid Arthritis: A Phase III Study. Rheumatology and Therapy 9:1, pages 175-189.
Crossref
Crossref
Jeffrey R. Curtis, Bradley Stolshek, Paul Emery, Boulos Haraoui, Elaine Karis, Greg Kricorian, David H. Collier, Priscilla K. Yen & Vivian P. Bykerk. (2022) Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology Publish Ahead of Print.
Crossref
Crossref
George P. Avramidis, Maria P. Avramidou & George A. Papakostas. (2021) Rheumatoid Arthritis Diagnosis: Deep Learning vs. Humane. Applied Sciences 12:1, pages 10.
Crossref
Crossref
Richard A Brook, Nathan L Kleinman & Ian A Beren. (2021) Rheumatoid Arthritis Disability and Absence Trends in the United States. Journal of Biomedical Research & Environmental Sciences 2:12, pages 1238-1245.
Crossref
Crossref
Christopher ArnellMartin BergmanDhiman BasuJames T KenneyJohanna B WithersJennifer LoganJeraldine Lim HarashimaErin Connolly-Strong. (2021) Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility. Journal of Managed Care & Specialty Pharmacy 27:12, pages 1734-1742.
Crossref
Crossref
Guiwu Huang, Jiahao Cai, Wenchang Li, Yanlin Zhong, Weiming Liao & Peihui Wu. (2021) Causal relationship between educational attainment and the risk of rheumatoid arthritis: a Mendelian randomization study. BMC Rheumatology 5:1.
Crossref
Crossref
Mingliang Zhong, Canhua Xu, Yaohong Wu, Qin Chen & Rongchun Chen. (2021) Scientific Productivity in Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology 27:8, pages e385-e390.
Crossref
Crossref
Elizabeth A. Holdsworth, Bethany Donaghy, Kathleen M. Fox, Pooja Desai, David H. Collier & Daniel E. Furst. (2021) Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis. Rheumatology and Therapy 8:4, pages 1637-1649.
Crossref
Crossref
Martin Bergman, Namita Tundia, Min Yang, Eli Orvis, Jerry Clewell & Arielle Bensimon. (2021) Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis. Advances in Therapy 38:12, pages 5649-5661.
Crossref
Crossref
Wei-Jen Chen, Hanoch Livneh, Chi-Hsien Chen, Hui-Ju Huang, Wen-Jiun Liu, Ming-Chi Lu & Tzung-Yi Tsai. (2021) Does Use of Acupuncture Reduce the Risk of Type 2 Diabetes Mellitus in Patients With Rheumatoid Arthritis? Evidence From a Universal Coverage Health Care System. Frontiers in Medicine 8.
Crossref
Crossref
Leon Lufkin, Marko Budišić, Sumona Mondal & Shantanu Sur. (2021) A Bayesian Model to Analyze the Association of Rheumatoid Arthritis With Risk Factors and Their Interactions. Frontiers in Public Health 9.
Crossref
Crossref
David L Scott, Fowzia Ibrahim, Harry Hill, Brian Tom, Louise Prothero, Rhiannon R Baggott, Ailsa Bosworth, James B Galloway, Sofia Georgopoulou, Naomi Martin, Isabel Neatrour, Elena Nikiphorou, Jackie Sturt, Allan Wailoo, Frances MK Williams, Ruth Williams & Heidi Lempp. (2021) Intensive therapy for moderate established rheumatoid arthritis: the TITRATE research programme. Programme Grants for Applied Research 9:8, pages 1-186.
Crossref
Crossref
Bryant R England, Punyasha Roul, Yangyuna Yang, Harlan Sayles, Fang Yu, Kaleb Michaud, Fenglong Xie, Jeffrey R Curtis & Ted R Mikuls. (2021) Burden and trajectory of multimorbidity in rheumatoid arthritis: a matched cohort study from 2006 to 2015. Annals of the Rheumatic Diseases 80:3, pages 286-292.
Crossref
Crossref
Sandhya Shri Kannayiram, Armaan Guraya, Chukwudi C Muojieje, Karun M Nair, Osahon N Idolor, Jesse Odion, Osaigbokan P Aihie & Eseosa Sanwo. (2020) An Analysis of Rheumatoid Arthritis Hospitalizations. Cureus.
Crossref
Crossref
Josef S. Smolen, Young Mo Kang, Wan-Hee Yoo, Paul Emery, Michael E. Weinblatt, Edward C. Keystone, Mark C. Genovese, Gihyun Myung, Inyoung Baek & Jeehoon Ghil. (2020) Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis. Arthritis Research & Therapy 22:1.
Crossref
Crossref
Shokufeh Nezamoleslami, Reza Ghiasvand, Awat Feizi, Mansour Salesi & Makan Pourmasoumi. (2020) The relationship between dietary patterns and rheumatoid arthritis: a case–control study. Nutrition & Metabolism 17:1.
Crossref
Crossref
Yirong Xiang, Qian Wang, Hongbin Li, Xinwang Duan, Yongfei Fang, Pingting Yang, Qin Li, Rui Wu, Yuehong Huo, Xiaofei Shi, Zhenbiao Wu, Yanhong Wang, Nan Jiang, Evelyn Hsieh, Mengtao Li, Xinping Tian & Xiaofeng Zeng. (2020) Chinese registry of rheumatoid arthritis (CREDIT): III. The transition of disease activity during follow‐ups and predictors of achieving treatment target. International Journal of Rheumatic Diseases 23:12, pages 1719-1727.
Crossref
Crossref
Devin IncertiErvant J. Maksabedian HernandezJoseph TkaczJeroen P. JansenDavid CollierMahdi GharaibehLaura Moore-SchiltzBradley S. Stolshek. (2020) The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis. Journal of Managed Care & Specialty Pharmacy 26:10, pages 1236-1242.
Crossref
Crossref
Mariam Riad, Daniel P. Dunham, Jacquelin R. Chua, Najia Shakoor, Sobia Hassan, Sarah Everakes, Joel A. Block & Isabel Castrejon. (2020) Health Disparities Among Hispanics With Rheumatoid Arthritis. JCR: Journal of Clinical Rheumatology 26:7, pages 279-284.
Crossref
Crossref
Phillip D. Rumrill, David R. Strauser, Chelsea Greco & Mykal J. Leslie. (2020) A Vocational Rehabilitation Intervention Framework for People With Rheumatoid Arthritis. Journal of Applied Rehabilitation Counseling 51:1, pages 16-30.
Crossref
Crossref
Atta Abbas Naqvi, Mohamed Azmi Hassali, Syed Baqir Shyum Naqvi, Bharti Kachela & Irfanullah Khan. (2019) Estimation of direct cost of managing rheumatoid arthritis treatment to Pakistani patients using real‐world follow‐up data. International Journal of Rheumatic Diseases 23:3, pages 325-333.
Crossref
Crossref
Natalie Boytsov, Xiang Zhang, Kristin A. Evans & Barbara H. Johnson. (2019) Impact of Plan-Level Access Restrictions on Effectiveness of Biologics Among Patients with Rheumatoid or Psoriatic Arthritis. PharmacoEconomics - Open 4:1, pages 105-117.
Crossref
Crossref
Victoria Wickenheisser, Emilia Zywot, Emily Rabjohns, Natalia Orlova, Christina Marvin, Song Ding, David Lawrence & Teresa Tarrant. (2020) Photo-released drugs: a targeted treatment approach for arthritis. Photo-released drugs: a targeted treatment approach for arthritis.
Lauren MF Merlo, Jessica Bowers, Tony Stefanoni, Robert Getts & Laura Mandik-Nayak. (2020) B-Cell-Targeted 3DNA Nanotherapy Against Indoleamine 2,3-Dioxygenase 2 (IDO2) Ameliorates Autoimmune Arthritis in a Preclinical Model. Clinical Pathology 13, pages 2632010X2095181.
Crossref
Crossref
Josef S Smolen, Jung-Yoon Choe, Michael E Weinblatt, Paul Emery, Edward Keystone, Mark C Genovese, Gihyun Myung, Evelyn Hong, Inyoung Baek & Jeehoon Ghil. (2020) Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis. RMD Open 6:1, pages e001096.
Crossref
Crossref
Michele Russell-Westhead, Nicola O’Brien, Iain Goff, Elizabeth Coulson, Jess Pape & Fraser Birrell. (2020) Mixed methods study of a new model of care for chronic disease: co-design and sustainable implementation of group consultations into clinical practice. Rheumatology Advances in Practice 4:1.
Crossref
Crossref
Maria Gabriela Chancay, Shirin Nouri Guendsechadze & Irene Blanco. (2019) Types of pain and their psychosocial impact in women with rheumatoid arthritis. Women's Midlife Health 5:1.
Crossref
Crossref
Joshua J. Solomon, Sonye K. Danoff, Hilary J. Goldberg, Felix Woodhead, Martin Kolb, Daniel C. Chambers, Donna DiFranco, Cathy Spino, Shana Haynes-Harp, Shelley Hurwitz, Elizabeth B. Peters, Paul F. Dellaripa & Ivan O. Rosas. (2019) The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Advances in Therapy 36:11, pages 3279-3287.
Crossref
Crossref
JaeJin An, Eric Nyarko & Mohammad Adam Hamad. (2019) Prevalence of comorbidities and their associations with health-related quality of life and healthcare expenditures in patients with rheumatoid arthritis. Clinical Rheumatology 38:10, pages 2717-2726.
Crossref
Crossref
Heenam Kwon, Wendy E. Brown, Cassandra A. Lee, Dean Wang, Nikolaos Paschos, Jerry C. Hu & Kyriacos A. Athanasiou. (2019) Surgical and tissue engineering strategies for articular cartilage and meniscus repair. Nature Reviews Rheumatology 15:9, pages 550-570.
Crossref
Crossref
Anthony J. Esposito, Sarah G. Chu, Rachna Madan, Tracy J. Doyle & Paul F. Dellaripa. (2019) Thoracic Manifestations of Rheumatoid Arthritis. Clinics in Chest Medicine 40:3, pages 545-560.
Crossref
Crossref
Batko, Rolska-Wójcik & Władysiuk. (2019) Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment—A Systematic Literature Review. International Journal of Environmental Research and Public Health 16:16, pages 2966.
Crossref
Crossref
Marie Falahee, Axel Finckh, Karim Raza & Mark Harrison. (2019) Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid Arthritis. Clinical Therapeutics 41:7, pages 1346-1354.
Crossref
Crossref
Taehwan Park. (2019) Health care utilization and expenditures among adults with rheumatoid arthritis using specialty pharmaceuticals. Research in Social and Administrative Pharmacy 15:6, pages 724-729.
Crossref
Crossref
Devin Incerti, Jeffrey R. Curtis, Jason Shafrin, Darius N. Lakdawalla & Jeroen P. Jansen. (2019) A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis. PharmacoEconomics 37:6, pages 829-843.
Crossref
Crossref
Noemi Muszbek, Clare Proudfoot, Marie Fournier, Chieh-I Chen, Andreas Kuznik, Zsofia Kiss, Peter Gal & Kaleb Michaud. (2019) Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs. Advances in Therapy 36:6, pages 1337-1357.
Crossref
Crossref
Vincent Gosselin Boucher, Ines Colmegna, Claudia Gemme, Sara Labbe, Sandra Pelaez & Kim L. Lavoie. (2019) Interventions to improve vaccine acceptance among rheumatoid arthritis patients: a systematic review. Clinical Rheumatology 38:6, pages 1537-1544.
Crossref
Crossref
Ming-Chi Lu, Hanoch Livneh, Lei-Mei Chiu, Ning-Sheng Lai, Chia-Chou Yeh & Tzung-Yi Tsai. (2019) A survey of traditional Chinese medicine use among rheumatoid arthritis patients: a claims data–based cohort study. Clinical Rheumatology 38:5, pages 1393-1400.
Crossref
Crossref
Karina Raimundo, Joshua J. Solomon, Amy L. Olson, Amanda M. Kong, Ashley L. Cole, Aryeh Fischer & Jeffrey J. Swigris. (2019) Rheumatoid Arthritis–Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs and Mortality. The Journal of Rheumatology 46:4, pages 360-369.
Crossref
Crossref
JaeJin AnZoe Bider-CanfieldJenny KangEvo AlemaoSean E. ConnollyAntony T. LinT. Craig Cheetham. (2019) Economic Evaluation of Anticyclic Citrullinated Peptide Positivity in Rheumatoid Arthritis. Journal of Managed Care & Specialty Pharmacy 25:4, pages 469-477.
Crossref
Crossref
Siobhan Farley, Bonita Libman, Melinda Edwards, Carl J. Possidente & Amanda G. Kennedy. (2018) Nurse telephone education for promoting a treat‐to‐target approach in recently diagnosed rheumatoid arthritis patients: A pilot project. Musculoskeletal Care 17:1, pages 156-160.
Crossref
Crossref
Melanie D. WhittingtonR. Brett McQueenDaniel A. OllendorfRichard H. ChapmanVarun M. KumarPatricia G. SynnottFoluso AgboolaJonathan D. Campbell. (2019) Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis. Journal of Managed Care & Specialty Pharmacy 25:1, pages 80-87.
Crossref
Crossref
Beth I Wallace, Akbar K Waljee, Arlene Weissman, Tanner J Caverly & Sameer D Saini. (2019) Overuse of glucocorticoids in rheumatoid arthritis: a national survey of primary care physicians. Rheumatology Advances in Practice 3:1.
Crossref
Crossref
David M. Kern, Lawrence Chang, Kalyani Sonawane, Cynthia J. Larmore, Natalie N. Boytsov, Ralph A. Quimbo, Joseph Singer, John T. Hinton, Sze-jung Wu & Andre B. Araujo. (2018) Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population. Rheumatology and Therapy 5:2, pages 355-369.
Crossref
Crossref
George A. Kelley, Kristi S. Kelley & Leigh F. Callahan. (2018) Aerobic Exercise and Fatigue in Rheumatoid Arthritis Participants: A Meta‐Analysis Using the Minimal Important Difference Approach. Arthritis Care & Research 70:12, pages 1735-1739.
Crossref
Crossref
Lindsay ClaxtonMatthew TaylorArif SoonasraJeffrey A. BourretRobert A. Gerber. (2018) An Economic Evaluation of Tofacitinib Treatment in Rheumatoid Arthritis After Methotrexate or After 1 or 2 TNF Inhibitors from a U.S. Payer Perspective. Journal of Managed Care & Specialty Pharmacy 24:10, pages 1010-1017.
Crossref
Crossref
Andrew Hresko, Tzu-Chieh Lin & Daniel H. Solomon. (2018) Medical Care Costs Associated With Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-Analysis. Arthritis Care & Research 70:10, pages 1431-1438.
Crossref
Crossref
Cintia Scucuglia Heluany, Leonard de Vinci Kanda Kupa, Mariana Nascimento Viana, Cristina Maria Fernandes & Sandra Helena Poliselli Farsky. (2018) Hydroquinone exposure worsens the symptomatology of rheumatoid arthritis. Chemico-Biological Interactions 291, pages 120-127.
Crossref
Crossref
Yaakov A. Levine, Jesse Simon & Michael Faltys. (2018) Neurophysiologic and Chronic Safety Testing of a Miniaturized Active Implanted Device with Integrated Electrodes for Bioelectronic Medicine Applications. Neurophysiologic and Chronic Safety Testing of a Miniaturized Active Implanted Device with Integrated Electrodes for Bioelectronic Medicine Applications.
S. Jayashree, K. Nirekshana, Gunjan Guha & Dipita Bhakta-Guha. (2018) Cancer chemotherapeutics in rheumatoid arthritis: A convoluted connection. Biomedicine & Pharmacotherapy 102, pages 894-911.
Crossref
Crossref
Amit D. Raval & Ami Vyas. (2018) Trends in Healthcare Expenditures among Individuals with Arthritis in the United States from 2008 to 2014. The Journal of Rheumatology 45:5, pages 705-716.
Crossref
Crossref
François Jamar, Annibale Versari, Filippo Galli, Frédéric Lecouvet & Alberto Signore. (2018) Molecular Imaging of Inflammatory Arthritis and Related Disorders. Seminars in Nuclear Medicine 48:3, pages 277-290.
Crossref
Crossref
Jason ShafrinMahlet Gizaw TebekaKwanza PriceChad PatelKaleb Michaud. (2018) The Economic Burden of ACPA-Positive Status Among Patients with Rheumatoid Arthritis. Journal of Managed Care & Specialty Pharmacy 24:1, pages 4-11.
Crossref
Crossref
Chieh-I Chen, Li Wang, Wenhui Wei, Huseyin Yuce & Kristine Phillips. (2018) Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs. Rheumatology Advances in Practice 2:1.
Crossref
Crossref
Yaakov A. Levine, Jesse Simon, Michael Faltys & Ralph Zitnik. 2018. Neuromodulation. Neuromodulation
1503
1511
.
M. Kristen Demoruelle, Amy L. Olson & Joshua J. Solomon. 2018. Lung Disease in Rheumatoid Arthritis. Lung Disease in Rheumatoid Arthritis
45
58
.
BEVERLY K. JOHNSON & ASENA BAHÇE-ALTUNTAŞ. (2017) Too Little Too Late: Effect of Poor Access to Biologics for Patients with Rheumatoid Arthritis. The Journal of Rheumatology 44:12, pages 1765-1766.
Crossref
Crossref
Michael Grabner, Natalie N. Boytsov, Qing Huang, Xiang Zhang, Tingjian Yan & Jeffrey R. Curtis. (2017) Costs associated with failure to respond to treatment among patients with rheumatoid arthritis initiating TNFi therapy: a retrospective claims analysis. Arthritis Research & Therapy 19:1.
Crossref
Crossref
Edith M. Williams, Rebekah J. Walker, Trevor Faith & Leonard E. Egede. (2017) The impact of arthritis and joint pain on individual healthcare expenditures: findings from the Medical Expenditure Panel Survey (MEPS), 2011. Arthritis Research & Therapy 19:1.
Crossref
Crossref
Miao-Chiu Lin, Ming-Chi Lu, Hanoch Livneh, Ning-Sheng Lai, How-Ran Guo & Tzung-Yi Tsai. (2017) Factors associated with sexual dysfunction in Taiwanese females with rheumatoid arthritis. BMC Women's Health 17:1.
Crossref
Crossref
D. Shin, Y. Lee, H. Kim, T. Körnicke & R. Fuhr. (2017) A randomized phase I comparative pharmacokinetic study comparing SB5 with reference adalimumab in healthy volunteers. Journal of Clinical Pharmacy and Therapeutics 42:6, pages 672-678.
Crossref
Crossref
Elizabeth Hulen, Ayla Ervin, Allison Schue, Gina Evans-Young, Somnath Saha, Edward H. Yelin & Jennifer L. Barton. (2017) Patient goals in rheumatoid arthritis care: A systematic review and qualitative synthesis. Musculoskeletal Care 15:4, pages 295-303.
Crossref
Crossref
Marie Falahee, Gwenda Simons, Christopher D. Buckley, Mats Hansson, Rebecca J. Stack & Karim Raza. (2017) Patients' Perceptions of Their Relatives' Risk of Developing Rheumatoid Arthritis and of the Potential for Risk Communication, Prediction, and Modulation. Arthritis Care & Research 69:10, pages 1558-1565.
Crossref
Crossref
Alvin F. Wells, Jeffrey R. Curtis, Keith A. Betts, Kevin Douglas, Ella Xiaoyan Du & Arijit Ganguli. (2017) Systematic Literature Review and Meta-analysis of Tumor Necrosis Factor–Alpha Experienced Rheumatoid Arthritis. Clinical Therapeutics 39:8, pages 1680-1694.e2.
Crossref
Crossref
Wenhui Wei, Keith Knapp, Li Wang, Chieh-I Chen, Gary L. Craig, Karen Ferguson & Sergio Schwartzman. (2017) Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy. Advances in Therapy 34:8, pages 1936-1952.
Crossref
Crossref
Michael Masaracchio, William J. Hanney, Xinliang Liu, Morey Kolber & Kaitlin Kirker. (2017) Timing of rehabilitation on length of stay and cost in patients with hip or knee joint arthroplasty: A systematic review with meta-analysis. PLOS ONE 12:6, pages e0178295.
Crossref
Crossref
Tzung-Yi Tsai, Ming-Chi Lu, Hanoch Livneh, Shan-Yun Chiu, Ning-Sheng Lai & How-Ran Guo. (2017) Does depression increase the risk of stroke in patients with rheumatoid arthritis? A population-based cohort study. BMJ Open 7:4, pages e014233.
Crossref
Crossref
Jung-Yoon Choe, Nenad Prodanovic, Jaroslaw Niebrzydowski, Ivan Staykov, Eva Dokoupilova, Asta Baranauskaite, Roman Yatsyshyn, Mevludin Mekic, Wieskawa Porawska, Hana Ciferska, Krystyna Jedrychowicz-Rosiak, Agnieszka Zielinska, Jasmine Choi, Young Hee Rho & Josef S Smolen. (2017) A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy. Annals of the Rheumatic Diseases 76:1, pages 58-64.
Crossref
Crossref
Alan R. Erickson, Amy C. Cannella & Ted R. Mikuls. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology
1167
1186
.
Mauricio Rosas-Ballina. 2017. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases
123
144
.
James Harnett, Robert Gerber, David Gruben, Andrew S. KoenigConnie Chen. (2016) Evaluation of Real-World Experience with Tofacitinib Compared with Adalimumab, Etanercept, and Abatacept in RA Patients with 1 Previous Biologic DMARD: Data from a U.S. Administrative Claims Database. Journal of Managed Care & Specialty Pharmacy 22:12, pages 1457-1471.
Crossref
Crossref
Jonas K. Eriksson, Johan K. Wallman, Heather Miller, Ingemar F. Petersson, Sofia Ernestam, Nancy Vivar, Ronald F. van Vollenhoven & Martin Neovius. (2016) Infliximab Versus Conventional Combination Treatment and Seven‐Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial. Arthritis Care & Research 68:12, pages 1758-1766.
Crossref
Crossref
Kristine Carandang, Elizabeth A. Pyatak & Cheryl L. P. Vigen. (2016) Systematic Review of Educational Interventions for Rheumatoid Arthritis. The American Journal of Occupational Therapy 70:6, pages 7006290020p1-7006290020p12.
Crossref
Crossref
Paul Emery, Josef S. Smolen, Arijit Ganguli, Sebastian Meerwein, Yanjun Bao, Hartmut Kupper, Naijun Chen & Arthur Kavanaugh. (2016) Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate. Rheumatology 55:8, pages 1458-1465.
Crossref
Crossref
Frieda A. KoopmanSangeeta S. ChavanSanda MiljkoSimeon GrazioSekib SokolovicP. Richard SchuurmanAshesh D. MehtaYaakov A. Levine, Michael Faltys, Ralph Zitnik, Kevin J. TraceyPaul P. Tak. (2016) Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proceedings of the National Academy of Sciences 113:29, pages 8284-8289.
Crossref
Crossref
Su Wei Wan, Hong-Gu He, Anselm Mak, Manjari Lahiri, Nan Luo, Peter P. Cheung & Wenru Wang. (2016) Health-related quality of life and its predictors among patients with rheumatoid arthritis. Applied Nursing Research 30, pages 176-183.
Crossref
Crossref
Zheng-Yi Zhou, Jenny Griffith, Ella Xiaoyan Du, Daniel Chin, Keith A. Betts & Arijit Ganguli. (2016) Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid Arthritis. Advances in Therapy 33:5, pages 807-823.
Crossref
Crossref
Bruce C. M. Wang, Ping-Ning Hsu, Wesley Furnback, John Ney, Ya-Wen Yang, Chi-Hui Fang & Chao-Hsiun Tang. (2016) Estimating the Economic Burden of Rheumatoid Arthritis in Taiwan Using the National Health Insurance Database. Drugs - Real World Outcomes 3:1, pages 107-114.
Crossref
Crossref
Evo Alemao, Seongjung Joo, Hugh Kawabata, Maiwenn J. Al, Paul D. Allison, Maureen P. M. H. Rutten‐van Mölken, Michelle L. Frits, Christine K. Iannaccone, Nancy A. Shadick & Michael E. Weinblatt. (2016) Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data. Arthritis Care & Research 68:3, pages 308-317.
Crossref
Crossref
Ming-Chi Lu, How-Ran Guo, Miao-Chiu Lin, Hanoch Livneh, Ning-Sheng Lai & Tzung-Yi Tsai. (2016) Bidirectional associations between rheumatoid arthritis and depression: a nationwide longitudinal study. Scientific Reports 6:1.
Crossref
Crossref
Huan J. Chang, Daniel J. Finn, Dorothy D. Dunlop, Diego Tamez & Rowland W. Chang. 2016. CHRONIC DISEASE EPIDEMIOLOGY, PREVENTION, AND CONTROL, 4th edition. CHRONIC DISEASE EPIDEMIOLOGY, PREVENTION, AND CONTROL, 4th edition.
Ted R. Mikuls, Jeffrey B. Payne, Kevin D. Deane & Geoffrey M. Thiele. (2016) Autoimmunity of the lung and oral mucosa in a multisystem inflammatory disease: The spark that lights the fire in rheumatoid arthritis?. Journal of Allergy and Clinical Immunology 137:1, pages 28-34.
Crossref
Crossref
C.B. Horner, K. Low & J. Nam. 2016. Nanocomposites for Musculoskeletal Tissue Regeneration. Nanocomposites for Musculoskeletal Tissue Regeneration
213
240
.
Leena Kumari Prasad, Hannah O'Mary & Zhengrong Cui. (2015) Nanomedicine delivers promising treatments for rheumatoid arthritis. Nanomedicine 10:13, pages 2063-2074.
Crossref
Crossref
Onur Baser, Arijit Ganguli, Sanjoy Roy, Lin Xie & Mary Cifaldi. (2015) Impact of Switching From an Initial Tumor Necrosis Factor Inhibitor on Health Care Resource Utilization and Costs Among Patients With Rheumatoid Arthritis. Clinical Therapeutics 37:7, pages 1454-1465.
Crossref
Crossref
Jasvinder A Singh, Shahrzad Noorbaloochi, Carter Thorne, Glen S Hazlewood, Maria E Suarez-Almazor, Elizabeth Tanjong Ghogomu, George A Wells & Peter Tugwell. (2015) Subcutaneous or intramuscular methotrexate for rheumatoid arthritis. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jonas K Eriksson, Kari Johansson, Johan Askling & Martin Neovius. (2015) Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?. Annals of the Rheumatic Diseases 74:4, pages 648-654.
Crossref
Crossref
Josh J. Carlson, Sarika Ogale, Fred Dejonckheere & Sean D. Sullivan. (2015) Economic Evaluation of Tocilizumab Monotherapy Compared to Adalimumab Monotherapy in the Treatment of Severe Active Rheumatoid Arthritis. Value in Health 18:2, pages 173-179.
Crossref
Crossref
Miao-Chiu Lin, How-Ran Guo, Ming-Chi Lu, Hanoch Livneh, Ning-Sheng Lai & Tzung-Yi Tsai. (2015) Increased risk of depression in patients with rheumatoid arthritis: a seven-year population-based cohort study. Clinics 70:2, pages 91-96.
Crossref
Crossref
Diego Adhemar Jaitin, Hadas Keren-Shaul, Naama Elefant & Ido Amit. (2015) Each cell counts: Hematopoiesis and immunity research in the era of single cell genomics. Seminars in Immunology 27:1, pages 67-71.
Crossref
Crossref
Marieke Krol, Jocé Papenburg & Job van Exel. (2014) Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. PharmacoEconomics 33:2, pages 123-135.
Crossref
Crossref
Zhenhuan Zhang & Gordon F. Christopher. (2015) The nonlinear viscoelasticity of hyaluronic acid and its role in joint lubrication. Soft Matter 11:13, pages 2596-2603.
Crossref
Crossref
Jinoos Yazdany, Chris Tonner, Gabriela Schmajuk, Grace A. Lin & Amal N. Trivedi. (2014) Receipt of Glucocorticoid Monotherapy Among Medicare Beneficiaries With Rheumatoid Arthritis. Arthritis Care & Research 66:10, pages 1447-1455.
Crossref
Crossref
Joshua J. Kang, Mohammed A. Samad, Kye S. Kim & Soochan Bae. (2014) Comparative Anti-inflammatory Effects of Anti-arthritic Herbal Medicines and Ibuprofen. Natural Product Communications 9:9, pages 1934578X1400900.
Crossref
Crossref
Lyn March, Emma U.R. Smith, Damian G. Hoy, Marita J. Cross, Lidia Sanchez-Riera, Fiona Blyth, Rachelle Buchbinder, Theo Vos & Anthony D. Woolf. (2014) Burden of disability due to musculoskeletal (MSK) disorders. Best Practice & Research Clinical Rheumatology 28:3, pages 353-366.
Crossref
Crossref
Vincent Y. Ma, Leighton Chan & Kadir J. Carruthers. (2014) Incidence, Prevalence, Costs, and Impact on Disability of Common Conditions Requiring Rehabilitation in the United States: Stroke, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis, Limb Loss, and Back Pain. Archives of Physical Medicine and Rehabilitation 95:5, pages 986-995.e1.
Crossref
Crossref
Kevin D. Deane & Hani El-Gabalawy. (2014) Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE. Nature Reviews Rheumatology 10:4, pages 212-228.
Crossref
Crossref
Mark R. Rank & Thomas A. Hirschl. (2014) The risk of developing a work disability across the adulthood years. Disability and Health Journal 7:2, pages 189-195.
Crossref
Crossref
Z. Zhang, S. Barman & G. F. Christopher. (2014) The role of protein content on the steady and oscillatory shear rheology of model synovial fluids. Soft Matter 10:32, pages 5965-5973.
Crossref
Crossref
Onur Baser, Erdem Baser, Akif Altinbas & Abdulkadir Burkan. (2013) Severity index for rheumatoid arthritis and its association with health care costs and biologic therapy use in Turkey. Health Economics Review 3:1.
Crossref
Crossref
Jeffrey D. Greenberg, Tanya M. Spruill, Ying Shan, George Reed, Joel M. Kremer, Jeffrey Potter, Yusuf Yazici, Gbenga Ogedegbe & Leslie R. Harrold. (2013) Racial and Ethnic Disparities in Disease Activity in Patients with Rheumatoid Arthritis. The American Journal of Medicine 126:12, pages 1089-1098.
Crossref
Crossref
Kevin D. Deane. (2013) Can rheumatoid arthritis be prevented?. Best Practice & Research Clinical Rheumatology 27:4, pages 467-485.
Crossref
Crossref
Maria Goutsou, Ozgecan Uluscu, Angela Amend Kwasnik, Robert Stianchi, Paul M Peloso & Gillian Cannon. (2013) Biologics utilization for rheumatoid arthritis in the United States: An observational longitudinal study. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 13:2, pages 74-81.
Crossref
Crossref
Nathan L. Kleinman, Mary A. Cifaldi, James E. Smeeding, James W. Shaw & Richard A. Brook. (2013) Annual Incremental Health Benefit Costs and Absenteeism Among Employees With and Without Rheumatoid Arthritis. Journal of Occupational & Environmental Medicine 55:3, pages 240-244.
Crossref
Crossref
V. Metsis, P. Jangyodsuk, V. Athitsos, M. Iversen & F. Makedon. (2013) Computer aided rehabilitation for patients with rheumatoid arthritis. Computer aided rehabilitation for patients with rheumatoid arthritis.
W. Neal RobertsJr.Jr.. 2013. Kelley's Textbook of Rheumatology. Kelley's Textbook of Rheumatology
1034
1043
.
Elizabeth Salt & Leslie Crofford. (2012) Rheumatoid arthritis. The Nurse Practitioner 37:11, pages 16-22.
Crossref
Crossref
Christine A. McBurney & Ernest R. Vina. (2012) Racial and Ethnic Disparities in Rheumatoid Arthritis. Current Rheumatology Reports 14:5, pages 463-471.
Crossref
Crossref
Christine M. Nguyen, Mark Bounthavong, Margaret A.S. Mendes, Melissa L.D. Christopher, Josephine N. Tran, Rashid Kazerooni & Anthony P. Morreale. (2012) Cost Utility of Tumour Necrosis Factor-α Inhibitors for Rheumatoid Arthritis. PharmacoEconomics 30:7, pages 575-593.
Crossref
Crossref
Machaon M.K. Bonafede, Kathleen M. Fox, Barbara H. Johnson, Crystal Watson & Shravanthi R. Gandra. (2012) Factors Associated With the Initiation of Disease-Modifying Antirheumatic Drugs in Newly Diagnosed Rheumatoid Arthritis: A Retrospective Claims Database Study. Clinical Therapeutics 34:2, pages 457-467.
Crossref
Crossref
Fiona A. Russell & Jason J. McDougall. 2011. Proteases and Their Receptors in Inflammation. Proteases and Their Receptors in Inflammation
217
242
.
Ted R. Mikuls. (2010) Rheumatoid arthritis incidence: What goes down must go up?. Arthritis & Rheumatism 62:6, pages 1565-1567.
Crossref
Crossref